Free Trial

Coeptis Therapeutics (ZSQR) Insider Trading & Ownership

Coeptis Therapeutics logo
$13.82 -0.26 (-1.85%)
As of 04:00 PM Eastern

Coeptis Therapeutics (NASDAQ:ZSQR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.25%
Number Of
Insiders Buying
(Last 3 Years)
6
Amount Of
Insider Buying
(Last 3 Years)
$77.79K
Number Of
Insiders Selling
(Last 3 Years)
0
Get ZSQR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZSQR Insider Buying and Selling by Quarter

Coeptis Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/12/2024
Tara Desilva
Director
Buy113$11.60$1,310.80  
1/10/2024
Brian Cogley
CFO
Buy250$13.40$3,350.00  
1/8/2024
David Mehalick
CEO
Buy1,000$13.20$13,200.00  
1/5/2024
Daniel Alexander Yerace
VP
Buy542$13.80$7,479.60  
1/5/2024
David Mehalick
CEO
Buy252$13.80$3,477.60  
1/5/2024
Gene Salkind
Director
Buy580$13.80$8,004.00  
8/29/2023
Gene Salkind
Director
Buy200$20.20$4,040.00  
8/25/2023
Gene Salkind
Director
Buy1,431$18.20$26,044.20  
8/23/2023
Chris Calise
Director
Buy579$18.80$10,885.20  
(Data available from 1/1/2013 forward)

ZSQR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Coeptis Therapeutics includes Brian Cogley, Chris Calise, Daniel Alexander Yerace, David Mehalick, Gene Salkind, and Tara Desilva. Learn more on insiders at ZSQR.

24.25% of Coeptis Therapeutics stock is owned by insiders. Learn more on ZSQR's insider holdings.



This page (NASDAQ:ZSQR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners